Please login to the form below

Not currently logged in
Email:
Password:

Braeburn Pharmaceuticals

This page shows the latest Braeburn Pharmaceuticals news and features for those working in and with pharma, biotech and healthcare.

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant

FDA gives green light for opioid addiction implant. Titan and Braeburn's Probuphine is first implant of its kind to win US approval. ... The first implant treatment for opioid dependence will be launched in the US shortly following FDA approval for Titan

Latest news

  • FDA panel backs approval of first opioid addiction implant FDA panel backs approval of first opioid addiction implant

    FDA panel backs approval of first opioid addiction implant. Probuphine has been developed by Titan Pharma and partner Braeburn Pharma. ... At the committee meeting, Braeburn presented summary safety findings with a particular focus on the Probuphine

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics